{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:59:48Z","timestamp":1772823588856,"version":"3.50.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006546","name":"Angelini Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00374","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:50:11Z","timestamp":1585803011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo"],"prefix":"10.3389","volume":"11","author":[{"given":"Luigia","family":"Di Francesco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Ricciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Guillem-Llobat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alessandra","family":"Alisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Milanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garret A.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/HYPERTENSIONAHA.118.10833","article-title":"mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress","volume":"72","author":"Avenda\u00f1o","year":"2018","journal-title":"Hypertension"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23229","DOI":"10.1074\/jbc.M400443200","article-title":"Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile","volume":"279","author":"Boulet","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.bcp.2009.11.011","article-title":"Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro","volume":"79","author":"Bruno","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.4155\/fmc.11.136","article-title":"Identification and development of mPGES-1 inhibitors: where we are at","volume":"3","author":"Chang","year":"2011","journal-title":"Future Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1101\/gad.9.13.1586","article-title":"Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway","volume":"9","author":"Chen","year":"1995","journal-title":"Genes Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCRESAHA.108.191114","article-title":"Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells","volume":"104","author":"Di Francesco","year":"2009","journal-title":"Circ. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1126\/science.1103333","article-title":"COX-2-derived prostacyclin confers atheroprotection on female mice","volume":"306","author":"Egan","year":"2004","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/01.RES.0000214553.37930.3e","article-title":"De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin","volume":"98","author":"Evangelista","year":"2006","journal-title":"Circ. Res."},{"key":"B10","first-page":"3","article-title":"PPARgamma ligands as modulators of inflammatory and catabolic responses on arthritis: an overview","volume":"29","author":"Fahmi","year":"2002","journal-title":"J. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040576","article-title":"Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis","volume":"7","author":"Finetti","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/01.cir.67.6.1174","article-title":"Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease","volume":"67","author":"FitzGerald","year":"1983","journal-title":"Circulation"},{"key":"B13","first-page":"S31","article-title":"COX-2 inhibitors and the cardiovascular system","volume":"19","author":"FitzGerald","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","article-title":"Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population","volume":"52","author":"Garcia Rodriguez","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140452","article-title":"AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis","volume":"10","author":"Guma","year":"2015","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"28028","DOI":"10.1074\/jbc.M001387200","article-title":"Feedback control of cyclooxygenase-2 expression through PPARgamma","volume":"275","author":"Inoue","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1074\/jbc.M213290200","article-title":"Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis","volume":"278","author":"Kamei","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"33684","DOI":"10.1074\/jbc.M400199200","article-title":"Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1","volume":"279","author":"Kamei","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.plipres.2007.01.001","article-title":"Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation","volume":"46","author":"Kang","year":"2007","journal-title":"Prog. Lipid. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1172\/JCI9652","article-title":"15-deoxy-\u039412,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats","volume":"106","author":"Kawahito","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1124\/jpet.109.160663","article-title":"The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"332","author":"Koeberle","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1021\/acs.jmedchem.5b01750","article-title":"Design and development of microsomal prostaglandin E2 synthase-1 inhibitors: challenges and future directions","volume":"59","author":"Koeberle","year":"2016","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bcpt.12162","article-title":"Characterization of microsomal prostaglandin E synthase 1 inhibitors","volume":"114","author":"Korotkova","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.5483\/bmbrep.2005.38.6.633","article-title":"Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis","volume":"38","author":"Kudo","year":"2005","journal-title":"J. Biochem. Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/j.1476-5381.1995.tb15091.x","article-title":"Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"116","author":"Panara","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: From pharmacology to clinical read-outs","volume":"1851","author":"Patrignani","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B32","first-page":"1705","article-title":"Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"271","author":"Patrignani","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B33","first-page":"661","article-title":"COX-2 is not involved in thromboxane biosynthesis by activated human platelets","volume":"50","author":"Patrignani","year":"1999","journal-title":"J. Physiol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.brainresrev.2004.12.024","article-title":"New insights into COX-2 biology and inhibition","volume":"48","author":"Patrignani","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1074\/jbc.M109546200","article-title":"Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein","volume":"277","author":"Pontsler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8919","DOI":"10.1074\/jbc.271.15.8919","article-title":"Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2","volume":"271","author":"Pratico","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/13543776.2017.1344218","article-title":"Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review","volume":"27","author":"Psarra","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.4049\/jimmunol.0903107","article-title":"NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of I kappa B-alpha degradation in human monocytes","volume":"184","author":"Ricciotti","year":"2010","journal-title":"J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/CIA.S21107","article-title":"Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety","volume":"6","author":"Roth","year":"2011","journal-title":"Clin. Interv. Aging."},{"key":"B41","doi-asserted-by":"publisher","first-page":"R1100","DOI":"10.1152\/ajpregu.00872.2004","article-title":"Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1","volume":"288","author":"Saha","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharm. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.1096\/fj.201802547R","article-title":"miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction","volume":"33","author":"Saul","year":"2019","journal-title":"FASEB J."},{"key":"B44","first-page":"66","article-title":"The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain","volume":"57","author":"Sciulli","year":"2005","journal-title":"Pharm. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharm. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00393-012-1083-8","article-title":"Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology","volume":"72","author":"Snekhalatha","year":"2013","journal-title":"Z. Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0076-6879(07)33003-6","article-title":"Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC\/MS\/MS method","volume":"433","author":"Song","year":"2007","journal-title":"Methods Enzymol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in Health and Disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3748\/wjg.v18.i18.2147","article-title":"Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility","volume":"18","author":"Takeuchi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0090-6980(02)00024-2","article-title":"Cyclooxygenase isozymes and their gene structures and expression","author":"Tanabe","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI13416","article-title":"Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J. Clin. Invest."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"16579","DOI":"10.1074\/jbc.M412075200","article-title":"Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages","volume":"280","author":"Trebino","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/j.febslet.2006.04.040","article-title":"Inhibition of 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) endocytosis by ouabain in human endothelial cells","volume":"580","author":"Trevisi","year":"2006","journal-title":"FEBS Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.1073\/pnas.0606586103","article-title":"Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2796.2008.01938.x","article-title":"Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease","volume":"263","author":"Wang","year":"2008","journal-title":"J. Intern. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.110.973685","article-title":"Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCRESAHA.113.301033","article-title":"Cyclooxygenase-2-derived prostaglandin E2 promotes injury-induced vascular neointimal hyperplasia through the Eprostanoid 3 receptor","volume":"113","author":"Zhang","year":"2013","journal-title":"Circ. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T13:24:26Z","timestamp":1585920266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":60,"alternative-id":["10.3389\/fphar.2020.00374"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00374","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"article-number":"374"}}